Delhivery reported a consolidated net profit of Rs 72.56 crore in Q4 FY25, compared with net loss of Rs 68.47 crore in Q4 FY24.

JB Chemicals & Pharmaceuticals focuses on lozenges in CDM business, with minimal impact expected from US policy changes.

Arlo is a standout small-cap investment with impressive subscriber growth, early milestones, and upcoming cost-reducing ...

The bank’s total income rose to Rs 2,946 crore during the March quarter of 2024-25 as compared to Rs 2,621 crore in the same ...